Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 21, 2009; 15(31): 3874-3883
Published online Aug 21, 2009. doi: 10.3748/wjg.15.3874
Published online Aug 21, 2009. doi: 10.3748/wjg.15.3874
Clinicopathological features | n | PPARγ protein | χ2 | P | |
+ | - | ||||
Histologic subtype | 138 | 24.663 | 0.000 | ||
Intestinal type | 63 | 60 | 3 | ||
Diffuse type | 75 | 44 | 31 | ||
Depth of invasion | 138 | 1.183 | 0.277 | ||
Serosal | 24 | 16 | 8 | ||
Out of serosa | 114 | 88 | 26 | ||
Vessel invasion | 138 | 0.065 | 0.799 | ||
Absent | 120 | 90 | 30 | ||
Present | 18 | 14 | 4 | ||
Lymph node metastasis | 138 | 0.309 | 0.578 | ||
Absent | 36 | 28 | 8 | ||
Present | 102 | 76 | 28 | ||
Distant metastasis | 138 | 0.535 | 0.464 | ||
Absent | 126 | 96 | 30 | ||
Present | 12 | 8 | 4 | ||
Clinical stage1 | 126 | 0.017 | 0.897 | ||
I-II | 39 | 30 | 9 | ||
III-IV | 87 | 61 | 26 |
- Citation: Ma XM, Yu H, Huai N. Peroxisome proliferator-activated receptor-γ is essential in the pathogenesis of gastric carcinoma. World J Gastroenterol 2009; 15(31): 3874-3883
- URL: https://www.wjgnet.com/1007-9327/full/v15/i31/3874.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3874